IO Biotech Announces Board Changes
Ticker: IOBT · Form: 8-K · Filed: Nov 21, 2025 · CIK: 1865494
| Field | Detail |
|---|---|
| Company | Io Biotech, Inc. (IOBT) |
| Form Type | 8-K |
| Filed Date | Nov 21, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, board-of-directors
TL;DR
IO Biotech board shake-up: director out, new one in. Effective Nov 17.
AI Summary
IO Biotech, Inc. announced on November 17, 2025, a change in its board of directors. Specifically, the company reported the departure of a director and the election of a new director, effective on the same date. The filing also touches upon compensatory arrangements for certain officers.
Why It Matters
Changes in a company's board of directors can signal shifts in strategy, governance, or investor confidence.
Risk Assessment
Risk Level: low — This filing primarily concerns routine corporate governance changes and does not involve significant financial transactions or operational disruptions.
Key Players & Entities
- IO Biotech, Inc. (company) — Registrant
- November 17, 2025 (date) — Effective date of board changes
FAQ
Who departed from the IO Biotech board of directors?
The filing indicates the departure of a director, but the specific name is not provided in the summary information.
Who was elected to the IO Biotech board of directors?
The filing states that a new director was elected, but the specific name is not detailed in the provided summary.
What is the effective date of these board changes?
The changes to the board of directors are effective as of November 17, 2025.
Does this filing mention any changes to executive officers?
The filing notes 'Appointment of Certain Officers' and 'Compensatory Arrangements of Certain Officers' as items being reported, suggesting potential changes or updates related to officers.
What is the primary business of IO Biotech, Inc.?
IO Biotech, Inc. is in the Pharmaceutical Preparations industry, SIC code 2834.
Filing Stats: 518 words · 2 min read · ~2 pages · Grade level 11.2 · Accepted 2025-11-21 16:44:15
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share IOBT The Nasdaq Stock Mar
Filing Documents
- d74446d8k.htm (8-K) — 23KB
- 0001193125-25-291504.txt ( ) — 134KB
- iobt-20251117.xsd (EX-101.SCH) — 3KB
- iobt-20251117_lab.xml (EX-101.LAB) — 17KB
- iobt-20251117_pre.xml (EX-101.PRE) — 11KB
- d74446d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IO BIOTECH, INC. Date: November 21, 2025 By: /s/ Mai-Britt Zocca, Ph.D. Name: Mai-Britt Zocca, Ph.D. Title: Chief Executive Officer